questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Manifestations neurologiques
Paralysie
Hémiplégie
Hémiplégie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hémiplégie
Imagerie par résonance magnétique
Évaluation neurologique
Tests fonctionnels
Électromyographie
Fonction musculaire
Signes cliniques
Faiblesse musculaire
Hémiparésie
Troubles neurologiques
Symptômes
5
Symptômes
Troubles de la parole
Sensibilité
Pertes de sensation
Douleurs neuropathiques
Douleurs musculo-squelettiques
Troubles cognitifs
Mémoire
Prévention
5
Exercice
Accidents vasculaires cérébraux
Alimentation saine
Santé cardiovasculaire
Traitements
5
Rééducation physique
Ergothérapie
Anticoagulants
Anti-inflammatoires
Acupuncture
Thérapie par le mouvement
Complications
5
Infections
Problèmes de déglutition
Problèmes respiratoires
Faiblesse musculaire
Thrombose veineuse profonde
Risque accru
Escarres
Immobilité prolongée
Facteurs de risque
5
Antécédents familiaux
Risque d'AVC
Stress
Problèmes cardiovasculaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémiplégie : Questions médicales les plus fréquentes",
"headline": "Hémiplégie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémiplégie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémiplégie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Paralysie",
"url": "https://questionsmedicales.fr/mesh/D010243",
"about": {
"@type": "MedicalCondition",
"name": "Paralysie",
"code": {
"@type": "MedicalCode",
"code": "D010243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.636"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hémiplégie",
"alternateName": "Hemiplegia",
"code": {
"@type": "MedicalCode",
"code": "D006429",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohamad A Mikati",
"url": "https://questionsmedicales.fr/author/Mohamad%20A%20Mikati",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC. mohamad.mikati@dm.duke.edu."
}
},
{
"@type": "Person",
"name": "Lyndsey Prange",
"url": "https://questionsmedicales.fr/author/Lyndsey%20Prange",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC."
}
},
{
"@type": "Person",
"name": "Julie Uchitel",
"url": "https://questionsmedicales.fr/author/Julie%20Uchitel",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC."
}
},
{
"@type": "Person",
"name": "April Boggs",
"url": "https://questionsmedicales.fr/author/April%20Boggs",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA."
}
},
{
"@type": "Person",
"name": "Milton Pratt",
"url": "https://questionsmedicales.fr/author/Milton%20Pratt",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37356719",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.104956"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using genetics to explore complement C5 as a druggable protein in periodontitis.",
"datePublished": "2024-10-08",
"url": "https://questionsmedicales.fr/article/39439802",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1407431"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of multivalent complexes formed in the presence of more than one conventional antibody to terminal complement component C5.",
"datePublished": "2023-04-20",
"url": "https://questionsmedicales.fr/article/37079521",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0284502"
}
},
{
"@type": "ScholarlyArticle",
"name": "Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35947526",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.77503"
}
},
{
"@type": "ScholarlyArticle",
"name": "Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report.",
"datePublished": "2024-07-15",
"url": "https://questionsmedicales.fr/article/39009967",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12882-024-03662-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Paralysie",
"item": "https://questionsmedicales.fr/mesh/D010243"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hémiplégie",
"item": "https://questionsmedicales.fr/mesh/D006429"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémiplégie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémiplégie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémiplégie",
"description": "Comment diagnostique-t-on l'hémiplégie ?\nQuels tests sont utilisés pour évaluer l'hémiplégie ?\nL'électromyographie est-elle utile ?\nQuels signes cliniques indiquent l'hémiplégie ?\nL'hémiplégie peut-elle être confondue avec d'autres conditions ?",
"url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Complement+C5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémiplégie",
"description": "Quels sont les symptômes de l'hémiplégie ?\nL'hémiplégie affecte-t-elle la sensibilité ?\nPeut-on avoir des douleurs avec l'hémiplégie ?\nY a-t-il des troubles cognitifs associés ?\nL'hémiplégie peut-elle causer des problèmes émotionnels ?",
"url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Complement+C5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémiplégie",
"description": "Comment prévenir l'hémiplégie ?\nL'exercice régulier aide-t-il ?\nUne alimentation saine est-elle importante ?\nFaut-il éviter le tabac ?\nLe stress peut-il influencer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Complement+C5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémiplégie",
"description": "Quels traitements sont disponibles pour l'hémiplégie ?\nLa physiothérapie est-elle efficace ?\nDes médicaments sont-ils prescrits ?\nLa chirurgie est-elle une option ?\nQuelles sont les approches complémentaires ?",
"url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Complement+C5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémiplégie",
"description": "Quelles complications peuvent survenir ?\nL'hémiplégie peut-elle entraîner des problèmes respiratoires ?\nY a-t-il un risque de thrombose ?\nDes troubles de la peau peuvent-ils se développer ?\nL'hémiplégie peut-elle affecter la santé mentale ?",
"url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Complement+C5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémiplégie",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe mode de vie influence-t-il le risque ?\nLe stress est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Complement+C5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'hémiplégie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et des imageries cérébrales comme l'IRM."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'hémiplégie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests neurologiques et des évaluations fonctionnelles sont utilisés pour mesurer la gravité."
}
},
{
"@type": "Question",
"name": "L'électromyographie est-elle utile ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à évaluer la fonction musculaire et la conduction nerveuse."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent l'hémiplégie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent une faiblesse unilatérale, des réflexes anormaux et des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "L'hémiplégie peut-elle être confondue avec d'autres conditions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres troubles neurologiques comme l'hémiparésie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hémiplégie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une paralysie d'un côté, des troubles de la parole et des difficultés motrices."
}
},
{
"@type": "Question",
"name": "L'hémiplégie affecte-t-elle la sensibilité ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des pertes de sensation ou des sensations anormales du côté affecté."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs avec l'hémiplégie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs neuropathiques ou musculo-squelettiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des troubles cognitifs associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration."
}
},
{
"@type": "Question",
"name": "L'hémiplégie peut-elle causer des problèmes émotionnels ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes comme la dépression et l'anxiété sont fréquents après un AVC."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hémiplégie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le contrôle des facteurs de risque comme l'hypertension et le diabète."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire le risque d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Une alimentation saine est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée aide à maintenir une bonne santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Faut-il éviter le tabac ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque d'AVC et d'hémiplégie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des problèmes de santé augmentant le risque d'AVC."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'hémiplégie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la rééducation physique, l'ergothérapie et des médicaments."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie aide à améliorer la mobilité et la force musculaire."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils prescrits ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les anticoagulants ou les anti-inflammatoires peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la chirurgie peut être envisagée pour traiter des complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les approches complémentaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme l'acupuncture ou la thérapie par le mouvement peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des problèmes de déglutition et des contractures."
}
},
{
"@type": "Question",
"name": "L'hémiplégie peut-elle entraîner des problèmes respiratoires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes respiratoires peuvent survenir en raison de la faiblesse musculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de thrombose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de thrombose veineuse profonde est accru chez les patients hémiplégiques."
}
},
{
"@type": "Question",
"name": "Des troubles de la peau peuvent-ils se développer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des escarres peuvent se former en raison d'une immobilité prolongée."
}
},
{
"@type": "Question",
"name": "L'hémiplégie peut-elle affecter la santé mentale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles mentaux comme la dépression sont fréquents après un AVC."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'hémiplégie augmente avec l'âge, surtout après 55 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'AVC augmentent le risque d'hémiplégie."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des problèmes cardiovasculaires et d'AVC."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/02/2025
Contenu vérifié selon les dernières recommandations médicales
12 publications dans cette catégorie
Affiliations :
From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC. mohamad.mikati@dm.duke.edu.
11 publications dans cette catégorie
Affiliations :
From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC.
8 publications dans cette catégorie
Affiliations :
From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC.
4 publications dans cette catégorie
Affiliations :
Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA.
Publications dans "Hémiplégie" :
4 publications dans cette catégorie
Affiliations :
Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA.
Publications dans "Hémiplégie" :
4 publications dans cette catégorie
Affiliations :
Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA.
Publications dans "Hémiplégie" :
4 publications dans cette catégorie
Affiliations :
Division of Pediatric Neurology and Developmental Medicine, Duke Children's Health Center, 2301 Erwin Rd, Durham, NC, 27710, USA. Electronic address: keri.register@duke.edu.
Publications dans "Hémiplégie" :
4 publications dans cette catégorie
Publications dans "Hémiplégie" :
3 publications dans cette catégorie
Affiliations :
From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC.
Publications dans "Hémiplégie" :
3 publications dans cette catégorie
Affiliations :
From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC.
Publications dans "Hémiplégie" :
3 publications dans cette catégorie
Affiliations :
Child Neurology Section, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas. Electronic address: dsamanta@uams.edu.
Publications dans "Hémiplégie" :
3 publications dans cette catégorie
Affiliations :
Department of Psychiatry and Behavioral Sciences, Duke Pediatric Neuropsychology Program, Duke University, Durham, NC, USA.
Publications dans "Hémiplégie" :
3 publications dans cette catégorie
Affiliations :
From Sleep Disorders and Functional Neurology (E.P., A.A.), Department of Paediatric Clinical Epileptology, University Hospitals of Lyon, member of the ERN EpiCARE; Service de Neurologie Pédiatrique (D.D., T.B.), Hôpital Trousseau, APHP, Paris; Centre d'Investigation Clinique (E.N., N.N.), CHU Montpellier; Department of Medical Genetics (G.L.), Centre de Biologie Est, Lyon University Hospital, Hospices Civils de Lyon, member of the ERN EpiCARE; Laboratoire de Génétique (F.R.), Groupe Hospitalier Lariboisière-Fernand Widal AP-HP, Paris; IGF (S.N.), Univ Montpellier, CNRS, INSERM; Département de Neuropédiatrie (C.D., A.R.), CHU Gui de Chauliac, Montpellier; Service de Neuropédiatrie et Handicaps (M.A.B.), Hôpital Gatien de Clocheville, CHU Tours, France; Pediatric Neurology Unit (M.C.N.), Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium; Service de Neuropédiatrie (A.D.), CHU de Bicêtre, Kremlin-Bicêtre; Service de Neuropédiatrie (L.V.), CHU Lille; Service de Neurochirurgie Pédiatrique (M.B.), Hôpital Necker-Enfants Malades, APHP, Paris; Service de Neurologie Pédiatrique (C.I.), Hôpital Raymond Poincarré, AP-HP, Garches; Service de Neurophysiologie (C.G.), Hôpital Necker, AP-HP, Paris; Département de Pédiatrie (C.L.), CHU Limoges; Service de Neurologie Pédiatrique (M.M.), CHU Timone Enfants, Marseille; Centre de Référence "Déficiences Intellectuelles de Causes Rares" (V.D.P.), Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, Université de Lyon; and INSERM U 1051 (A.R.), Institut des Neurosciences de Montpellier, France.
Publications dans "Hémiplégie" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Chalfont Centre for Epilepsy, Chalfont St. Peter, United Kingdom.
Publications dans "Hémiplégie" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Chalfont Centre for Epilepsy, Chalfont St. Peter, United Kingdom.
Publications dans "Hémiplégie" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Chalfont Centre for Epilepsy, Chalfont St. Peter, United Kingdom.
Publications dans "Hémiplégie" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Chalfont Centre for Epilepsy, Chalfont St. Peter, United Kingdom.
Children's Hospital A. Meyer, University of Florence, Paediatric Neurology, Neuroscience Department, Florence, Italy.
Publications dans "Hémiplégie" :
2 publications dans cette catégorie
Affiliations :
National Center of Rehabilitation, Athens, Greece.
National Kapodistrian University of Athens, Laboratory Research of Musculoskeletal Disorders, Greece.
Publications dans "Hémiplégie" :
2 publications dans cette catégorie
Affiliations :
From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC.
Publications dans "Hémiplégie" :
2 publications dans cette catégorie
Affiliations :
From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC.
Publications dans "Hémiplégie" :
The human complement system plays a crucial role in immune defense. However, its erroneous activation contributes to many serious inflammatory diseases. Since most unwanted complement effector functio...
An excessively activated or dysregulated complement system has been proven to be a vital contributor to the pathogenesis of periodontitis. It has been previously hypothesized that inhibiting the activ...
In our primary analysis, we used 26 independent 'cis' single nucleotide polymorphisms as IVs from the vicinity of the encoding locus of C5 that are associated with plasma C5 levels. In a secondary ana...
In our primary approach, inhibiting C5 reduced the risk of periodontitis (Odds ratio 0.89 per 1 standard deviation reduction in C5; 95% confidence Interval 0.80-0.98,...
The findings from our study suggest that C5 inhibition may reduce the risk of periodontitis, prioritizing C5 inhibitors as a potential adjunctive therapeutic intervention in this disease....
This study sought to understand the nature of the immune complexes that could be formed when a patient is exposed simultaneously to two different anti-complement component 5 (C5) antibodies, such as i...
The membrane attack complex (MAC or C5b-9) is an important effector of the immune system to kill invading microbes. MAC formation is initiated when complement enzymes on the bacterial surface convert ...
No reports have shown histological changes before and after anti-C5 monoclonal antibody treatment in patients with atypical hemolytic uremic syndrome (aHUS). Here, we report a rare case of complement-...
A 53-year-old woman developed aHUS with CFH gene mutation [c.3572C > T (p. Ser1191 Leu)] and anti-CFH antibodies. Her father had succumbed to acute kidney injury (AKI) in his 30 s. She exhibited AKI, ...
This is the first report showing the pathophysiology of aHUS in the kidneys and the efficacy of anti-C5 monoclonal antibody treatment by presenting serial kidney pathological features before and after...
The efficacy and safety of complement inhibition in COVID-19 patients is unclear....
A multicenter randomized controlled, open-label trial. Hospitalized COVID-19 patients with signs of systemic inflammation and hypoxemia (PaO...
81 patients were randomly assigned to zilucoplan (n = 55) or the control group (n = 26). 78 patients were included in the safety and primary analysis. Most were men (87%) and the median age was 63 yea...
Administration of zilucoplan to COVID-19 patients in this proof-of-concept randomized trial was well tolerated under antibiotic prophylaxis. While not reaching statistical significance, indicators of ...
The Phase 3 single-arm COMMODORE 3 study (ClinicalTrials.gov, NCT04654468) evaluated efficacy and safety of crovalimab (novel C5 inhibitor) in complement inhibitor-naive patients with paroxysmal noctu...
The complement system is an essential component of our innate defense and plays a vital role in the pathogenesis of many diseases. Assessment of complement activation is critical in monitoring both di...
We performed a systematic analysis of the current methods used to assess complement components and reviewed whether the identified studies performed their complement measurements according to the reco...
A literature search using the Pubmed/MEDLINE database was performed focusing on studies measuring the key complement components C3, C5 and/or their split products and/or the soluble variant of the ter...
A total of 92 out of 376 studies were selected for full-text analysis. Forty-five studies (49%) were identified as using the correct sample type and techniques for their complement analyses, while 25 ...
A substantial part of the reviewed studies did not use the appropriate sample type for assessing complement activation or did not mention which sample type was used. This deviation from the standardiz...
Several patients with myasthenia gravis (MG) do not adequately respond to available drugs or exhibit poor tolerance, necessitating the need for new therapies....
The paper discusses the rapidly evolving target-specific immunotherapies that promise long-standing remissions in the management of MG. It is specifically focused on the role of complement, anti-compl...
Anti-AChR antibodies cause internalization of the receptors and activate complement leading to...
C3 is a key complement protein, located at the nexus of all complement activation pathways. Extracellular, tissue, cell-derived, and intracellular C3 plays critical roles in the immune response that i...